Brevan Howard Capital Management LP Cor Medix Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 146,489 shares of CRMD stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
146,489
Previous 19,704
643.45%
Holding current value
$1.66 Million
Previous $242,000
624.38%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
204Shares Held
41.2MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...